Cost per DALY averted in low, middle- and high-income countries: evidence from the global burden of disease study to estimate the cost-effectiveness thresholds

BACKGROUND: Determining the cost-effectiveness thresholds for healthcare interventions has been a severe challenge for policymakers, especially in low- and middle-income countries. This study aimed to estimate the cost per disability-adjusted life-year (DALY) averted for countries with different lev...

Descripción completa

Detalles Bibliográficos
Autores principales: Daroudi, Rajabali, Akbari Sari, Ali, Nahvijou, Azin, Faramarzi, Ahmad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863358/
https://www.ncbi.nlm.nih.gov/pubmed/33541364
http://dx.doi.org/10.1186/s12962-021-00260-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863358/
https://www.ncbi.nlm.nih.gov/pubmed/33541364
http://dx.doi.org/10.1186/s12962-021-00260-0

Ejemplares similares